martes, 6 de agosto de 2019

Blood test could replace biopsy for rare cancer treated by Keytruda - STAT

Blood test could replace biopsy for rare cancer treated by Keytruda - STAT

Cancer Briefing

STAT Plus: Blood test could replace biopsy for rare cancer treated by Keytruda

By MATTHEW HERPER


SAURABH DAS/AP
Currently, identifying such cancers, called MSI-High, for “microsatellite instable-high,” requires a biopsy of a tumor that had been surgically removed.

No hay comentarios: